|
|
Effects of sodium butyrate acid on kidney blood flow and microvascular permeability in rats with severe scald injury |
TANG Fubo1,3, GUO Jing2, ZHENG Jinguang1, BAI Xiaodong1 |
1. Department of Burn and Plastic Surgery, 2. Medical Department,General Hospital of the Chinese People’s Armed Police Forces,Beijing 100039,China; 3. Logistics University of Chinese People’s Armed Police Forces,Tianjin 300309,China |
|
|
Abstract Objective To investigate the protective effects of sodium butyrate on kidney of rats following 50%TBSA full-thickness burns. Methods 48 SD rats, weighing 250~270g, were randomly divided into three groups: sham group, scald group, sodium butyrate group (n=16 each). Rats were subjected to 50% TBSA third-degree burns by immersing the back for 15 seconds and the abdomen for 8 seconds in 100 ℃ water. The sham group was immersed in 37 ℃ water instead. Then 1ml sodium butyrate (400 mg/kg) or 1ml normal saline was intraperitoneally injected, respectively. Renal blood flow was measured by Doppler 3 and 6 hours after injury. Blood were drawn from the heart at 3 and 6 hours after injury for measurement of plasma creatinine (Cr); then the rats were sacrificed and kidney tissues were harvested for the measurement of microvascular permeability and the changes in tissue water content. Results Compared with scald group, the level of Cr and the rate of tissue water in sodium butyrate group were significantly lower at 3 and 6 hours after scald injury(all P<0.05); the microvascular permeability in sodium butyrate group was lower than in scald group at 6 hours after injury(all P<0.05), but had no significant difference at 3 hours after injury(P>0.05). In addition, sodium butyrate significantly increased the RBF level induced by scald injury at 3 and 6 hours(all P<0.05). Conclusion Sodium butyrate has significant protective effects on kidney by increaseing the RBF and inhibiting vasopermeability and tissue edema in rats with lethal scald injury.
|
Received: 06 March 2015
|
|
|
|
|
[1] |
Fessler E B, Chibane F L, Wang Z. Potential roles of HDAC inhibitors in mitigating ischemia-induced brain damage and facilitating endogenous regeneration and recovery[J]. Curr Pharm Des, 2013,19(28):5105-5120.
|
[2] |
Granger A, Abdullah I, Huebner F, et al. Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice[J]. FASEB J, 2008, 22(10):3549-3560.
|
[3] |
Gonzales E R, Chen H, Munuve R M, et al. Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock[J]. J Trauma, 2008, 65(3):554-565.
|
[4] |
Cianciolo C C, Skrypnyk N I, Brilli L L, et al. Histone deacetylase inhibitor enhances recovery after AKI[J]. J Am Soc Nephrol, 2013, 24(6):943-953.
|
[5] |
罗红敏,胡 森,盛志勇. 组蛋白去乙酰化酶抑制剂抗休克作用及其机制的研究进展[J].感染炎症修复, 2014, 15(01):60-64.
|
[6] |
Cao W, Bao C, Padalko E, Lowenstein C J. Acetylation of mitogen-activated protein kinase phosphatase-1 inhibits Toll-like receptor signaling[J]. J Exp Med, 2008, 205(6):1491-1503.
|
[7] |
Zhang L, Wan J, Jiang R, et al. Protective effects of trichostatin A on liver injury in septic mice[J]. Hepatol Res, 2009, 39(9):931-938.
|
[8] |
Zacharias N, Sailhamer E A, Li Y, et al. Histone deacetylase inhibitors prevent apoptosis following lethal hemorrhagic shock in rodent kidney cells[J]. Resuscitation, 2011, 82(1):105-109.
|
[9] |
Lee J S, Lee G M. Effect of sodium butyrate on autophagy and apoptosis in Chinese hamster ovary cells[J]. Biotechnol Prog, 2012, 28(2):349-357.
|
[10] |
Kato K, Kuhara A, Yoneda T, et al. Sodium butyrate inhibits the self-renewal capacity of endometrial tumor side-population cells by inducing a DNA damage response[J]. Mol Cancer Ther, 2011, 10(8):1430-1439.
|
[11] |
Jiang W, Guo Q, Wu J, et al. Dual effects of sodium butyrate on hepatocellular carcinoma cells)[J]. Mol Biol Rep, 2012, 39(5):6235-6242.
|
[12] |
Shin H, Lee Y S, Lee Y C. Sodium butyrate-induced DAPK-mediated apoptosis in human gastric cancer cells[J]. Oncol Rep, 2012, 27(4):1111-1115.
|
[13] |
夏 晨, 张建刚. 丁酸钠在仔猪生产上的应用研究进展[J]. 广东饲料, 2011, 20(3):26-28.
|
[14] |
Gundersen B B, Blendy J A. Effects of the histone deacetylase inhibitor sodium butyrate in models of depression and anxiety[J]. Neuropharmacology, 2009, 57(1):67-74.
|
[15] |
Chuang D M, Leng Y, Marinova Z, et al. Multiple roles of HDAC inhibition in neurodegenerative conditions[J]. Trends Neurosci, 2009, 32(11):591-601.
|
[16] |
Kilgore M, Miller C A, Fass D M, et al. Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer’s disease[J]. Neuropsychopharmacology, 2010, 35(4):870-880.
|
[17] |
Liang X, Wang R S, Wang F, et al. Sodium butyrate protects against severe burn-induced remote acute lung injury in rats[J]. Plos one, 2013, 8(7):191-195.
|
[18] |
Hu X, Zhang K, Xu C. Anti-inflammatory effect of sodium butyrate preconditioning during myocardial ischemiareperfusion[J]. Exp Ther Med, 2014, 8(1):229-232.
|
[19] |
Wang H B, Wang P Y, Wang X. Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription[J]. Dig Dis Sci,2012, 57(12): 3126-3135.
|
[20] |
Han X, Song H, Wang Y. Sodium butyrate protects the intestinal barrier function in peritonitic mice[J]. Int J Clin Exp Med, 2015, 8(3):4000-4007.
|
[1] |
. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2019, 30(8): 729-732. |
|
|
|
|